arrow
P

Paul L. Nguyen

queens university
H指数:83
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interpretable machine learning identifies health system levers for survival outcomes of patients with prostate cancer

可解释机器学习识别影响前列腺癌患者生存结果的健康系统杠杆

2026-10-020
PRE
Health services research and advocacy in US cancer care: pathways from evidence to implementation

美国癌症护理中的卫生服务研究与倡导:从证据到实施的途径

2026-09-010
OAAI
FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate plus Prednisone and Apalutamide

FORMULA-509:一项多中心随机试验,研究前列腺切除术后挽救性放射治疗与6个月GnRH激动剂联合比卡鲁胺或阿比特龙醋酸盐加泼尼松和阿帕鲁胺的疗效

2026-02-100
OAAI
CT online adaptive radiotherapy is associated with dosimetric and acute toxicity improvements in prostate cancer treatment

CT在线自适应放射治疗与前列腺癌治疗中的剂量学和急性毒性改善相关。

2025-10-170
PRE
Stereotactic magnetic resonance imaging-guided adaptive radiotherapy: a pooled analysis of a master prospective trial

立体定向磁共振成像引导自适应放射治疗:一项主前瞻性试验的合并分析

2025-09-010
PRE
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer

放疗与手术为基础的治疗策略在高风险前列腺癌中的比较

2025-07-190
PRE
The Burden of Genitourinary Malignancies in Southeast Asia from 1990 to 2021

1990年至2021年东南亚泌尿生殖系统恶性肿瘤的负担

2025-05-010
PRE
Prostate cancer screening in the Middle East and North Africa: a cross-sectional study on current practices
2025-02-080
OAAI
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

预测前列腺癌放疗剂量反应:NRG/RTOG 0126和SAKK 09/10随机III期试验中辐射特征验证

2025-02-010
OAAI
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium

雄激素抑制和前列腺放疗后的睾酮恢复 (TRANSPORT): 来自前列腺癌随机试验荟萃分析 (MARCAP) 联盟的五个随机试验的汇总分析

2025-01-011
PRE
Biochemical response to neoadjuvant androgen deprivation therapy before radiation therapy and the risk of death in patients with unfavorable-risk prostate cancer: A secondary analysis of a randomized clinical trial

放射治疗前对新辅助雄激素剥夺治疗的生化反应和不良风险前列腺癌患者的死亡风险: 一项随机临床试验的二次分析

CANCER
IF5.1
2024-12-040
PRE
Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers
2024-09-101
PRE
Insulin resistance during androgen deprivation therapy in men with prostate cancer

前列腺癌男性雄激素剥夺治疗期间的胰岛素抵抗

CANCER
IF5.1
2024-06-162
PRE
Remote operation of the DIII-D National Fusion Facility

Diii-d国家融合设施的远程操作

2024-05-201
OA